[7] The reactor is owned and operated by Egyptian Atomic Energy Authority (EAEA) at the Nuclear Research Center in Inshas, 60 kilometres (37 mi) northeast of Cairo.

Finally, Egypt announced international tender and among the bidders were the Canadian Atomic Energy of Canada Limited, the French Framatome and the Argentinian INVAP.

[9] In September 1992, a contract was signed between INVAP and the Egyptian Atomic Energy Authority (EAEA) and a branch office of INVAP in Nasr City was established to oversee the project with the construction works began in 1993 jointly by Argentina and Egypt.

[14] In 2004–2005, an investigation by International Atomic Energy Agency (IAEA) discovered that between 1999 and 2003, Egypt conducted about 4 unreported experiments using a total of 0.24 g of natural uranium compounds irradiated at the ETRR-2 to test the production of fission product isotopes for medical purposes.

The irradiated compounds had been dissolved in three laboratories located in the Nuclear Chemistry Building, but no plutonium or U-233 was separated during these experiments.